Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 186,980 | 240,387 | 187,843 | 200,918 | 220,943 |
| Marketable Securities | 3,918 | 2,451 | 3,003 | 13,053 | 23,130 |
| Other current assets | 13,526 | 5,832 | 5,796 | 5,855 | 5,944 |
| TOTAL | $204,424 | $248,670 | $196,642 | $219,826 | $250,017 |
| Non-Current Assets | |||||
| PPE Net | 6,180 | 6,272 | 6,955 | 7,573 | 8,007 |
| Investments And Advances | 15,110 | 492 | 0 | 0 | 0 |
| Other Non-Current Assets | 9,655 | 7,634 | 8,279 | 7,141 | 7,278 |
| TOTAL | $30,945 | $14,398 | $15,234 | $14,714 | $15,285 |
| Total Assets | $235,369 | $263,068 | $211,876 | $234,540 | $265,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,015 | 2,601 | 1,593 | 2,810 | 3,313 |
| Accrued Expenses | 25,394 | 22,760 | 19,060 | 12,283 | 16,564 |
| TOTAL | $38,957 | $34,780 | $30,098 | $25,231 | $30,274 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,641 | 6,637 | 6,812 | 7,581 | 7,891 |
| Other Non-Current Liabilities | 11,420 | 9,853 | 10,031 | 10,450 | 10,750 |
| TOTAL | $11,681 | $11,277 | $12,894 | $14,089 | $14,989 |
| Total Liabilities | $50,638 | $46,057 | $42,992 | $39,320 | $45,263 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,708 | 1,705 | 1,704 | 1,526 | N/A |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -303,072 | -265,358 | -232,232 | -202,414 | -174,740 |
| Other shareholders' equity | 452 | -250 | -251 | -227 | -188 |
| TOTAL | $184,731 | $217,011 | $168,884 | $195,220 | $220,039 |
| Total Liabilities And Equity | $235,369 | $263,068 | $211,876 | $234,540 | $265,302 |